
==== Front
Cureus
Cureus
2168-8184
Cureus
2168-8184
Cureus Palo Alto (CA)

10.7759/cureus.67345
Plastic Surgery
Dermatology
Ophthalmology
Parry-Romberg Syndrome: A Report of a Rare Case and a Comprehensive Review
Muacevic Alexander
Adler John R
Marappan Harikrishnan 1
AM Raja 2
1 Ophthalmology, Karuna Institute of Medical Sciences, Palakkad, IND
2 Ophthalmology, All India Institute of Medical Sciences, Madurai, IND
Harikrishnan Marappan stan_krish02@yahoo.co.in
20 8 2024
8 2024
16 8 e6734520 8 2024
Copyright © 2024, Marappan et al.
2024
Marappan et al.
https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This article is available from https://www.cureus.com/articles/281865-parry-romberg-syndrome-a-report-of-a-rare-case-and-a-comprehensive-review
Parry-Romberg syndrome (PRS), also recognized as progressive hemifacial atrophy (PHA), is a rare medical condition affecting the dermis, subcutaneous tissue, and occasionally underlying anatomical structures such as muscles and bones. While the etiology of this condition remains incompletely elucidated, it has been hypothesized that trauma, autoimmunity, infection, and autonomic dysregulation may constitute potential contributory factors. Typically, the onset of symptoms occurs within the initial two decades of life, though instances of late-onset PRS manifesting in the sixth and seventh decades of life have also been documented. The disorder is distinguished by a gradual progression over two to 20 years, ultimately culminating in stabilization.

The local manifestations of PRS are accompanied by systemic symptoms. Common neurological complications include seizures and headaches. Due to the rarity of PRS, there are no established guidelines for imaging, treatment, and follow-up. Therefore, management is tailored to each case, with treatment options primarily addressing symptoms.

management
facial asymmetry
neurocutaneous disorder
progressive hemifacial atrophy
parry-romberg syndrome
==== Body
pmcIntroduction

Parry-Romberg syndrome (PRS), also known as idiopathic hemifacial atrophy or progressive facial hemiatrophy (PFH), is a rare condition characterized by progressive unilateral facial atrophy. Its historical roots can be traced back to ancient Egypt, as formally documented by Caleb Hillier Parry and later by Moritz Heinrich Romberg [1].

The incidence of PRS ranges from 0.3 to 2.5 cases per 100,000 population annually, with a male-to-female ratio of 1 to 3 [2]. It typically develops during the first two decades of life, with the average age of diagnosis being 13.2 years. This early onset underscores the importance of early detection and intervention, particularly in males, who tend to be diagnosed even earlier [3].

The exact cause of PRS remains unclear, but it is posited to involve autoimmune, genetic, and neurovascular factors. The primary effects target the skin and subcutaneous tissue and may impact musculoskeletal and central nervous system structures. They culminate in disfiguring facial changes and complications affecting bone and soft tissue integrity [4].

If left untreated, PRS can progress to a burn-out phase within two to 20 years of active disease activity. This progression often leads to pronounced facial asymmetry and disfigurement. Ocular manifestations, from uveitis to keratitis to retinal pathologies, require ongoing management. Recurrent episodes of uveitis or retinal vasculitis may result in secondary glaucoma with varying visual prognoses. Neurological manifestations, while often well-managed, can result in minimal disability, underscoring the severity of the condition and the need for ongoing management [5].

Case presentation

During a regular eye checkup at our ophthalmology clinic, a 28-year-old woman mentioned that she had been noticing gradual changes in her facial appearance and intermittent headaches over the past five years. She described the thinning of the skin and soft tissues on the left side of her face, which had led to a noticeable decrease in the size of her left cheek and temple. Notably, the patient had no history of physical trauma, systemic illness, or family history of similar conditions. Upon physical examination, our team observed hemifacial atrophy on the left side of her face, affecting her forehead, cheek, and chin. The skin on the affected area appeared thin and atrophic, with a visible loss of subcutaneous tissue. There were no signs of facial nerve involvement or other neurological deficits. The ophthalmic assessment utilizing Hertel's exophthalmometer revealed a 2mm enophthalmos on the left side, while the remaining ophthalmic evaluations were within the normal range (Figure 1).

Figure 1 A patient diagnosed with PRS exhibits hemifacial atrophy on the left side of the face, including the forehead, cheek, and chin (red arrows), as well as 2mm of enophthalmos on the left side.

PRS: Parry-Romberg syndrome

Diagnostic workup

Based on our evaluation of the patient's clinical symptoms, we suspected PRS. We conducted extensive laboratory investigations, including a complete blood count, inflammatory markers, an autoimmune panel, and serological tests for infectious diseases. The results of these tests, all within normal limits, provided reassurance that there were no systemic causes for the observed facial atrophy. However, the patient chose not to pursue further investigations.

Management

In light of the progressive nature of PRS and the absence of definitive cures, patient management primarily centers on addressing cosmetic concerns and functional limitations. The patient received comprehensive counseling regarding the condition's natural progression and the crucial significance of regular monitoring to identify potential complications. Despite this guidance, the patient chose not to pursue any further treatment.

Discussion

Parry-Romberg syndrome is a rare medical condition with a wide range of clinical symptoms, which can make it challenging to diagnose and treat. While it can impact individuals of any gender, it is more commonly seen in females [4]. It is important to note that this disorder typically manifests during the first two decades of life, although there have been documented cases of the disease occurring later in life [5,6]. It progresses slowly and often resolves in two to 10 years before stabilizing [7]. The specific cause of the disease remains unknown, although several theories, including autoimmune and neurovascular explanations, have been proposed [8,9].

This medical condition is characterized by progressive hemifacial atrophy of the skin and craniofacial tissue, typically affecting the dermatomes innervated by one or more branches of the fifth cranial nerve [7,10]. It leads to a concave facial appearance due to the atrophy of subcutaneous adipose tissue and muscular and osteocartilaginous structures [7]. While cutaneous involvement is limited, the condition may extend to the tongue, gingiva, teeth, and palate [8,11]. It commonly affects the ocular region, resulting in enophthalmos, pseudoptosis, uveitis, pupillary disturbances, heterochromia, and restrictive strabismus. The principal ocular manifestation is enophthalmos, arising from the depletion of adipose tissue surrounding the affected orbit [12,13]. In our case, the patient showed a 2 mm enophthalmos on the left side.

This syndrome is associated with various neurological complications, including trigeminal neuralgia, facial paresthesia, migraines, and seizures. Contralateral epilepsy is a rare occurrence. In our patient's case, a headache was the only observed clinical manifestation. Notably, characteristic features of PRS include tongue atrophy on the affected side, deviation of the mouth and nose toward the affected side, atrophy of the upper lip leading to teeth exposure, and small teeth with short roots on the affected side [14-16]. However, these features were absent in our patient.

As per Guerrerosantos et al. [16], PRS can be categorized into four types based on facial soft tissue depletion severity. Types 1 and 2 involve a reduction in facial soft tissue, whereas types 3 and 4 involve thinning of soft tissue and bone and cartilage atrophy. Type 1 represents the mildest form, while type 4 signifies the most severe and critical form. In this instance, our patient has been diagnosed with type 3 PRS, indicating a reduction and thinning of subcutaneous soft tissue on the left side of the face.

The patient demonstrates left-sided facial asymmetry characterized by hemiatrophy, a prominent left forehead with bony ridges due to loss of fatty tissue beneath the skin, 2mm enophthalmos on the left side, minimal pigmentation over the conjunctiva, and minimal hair loss. These findings are consistent with the classic features of PRS as outlined in previous literature [16]. The patient's neurological and ocular findings are within normal limits, except for enophthalmos, and the patient exhibits normal psychomotor functions.

Effective management of PRS necessitates a multidisciplinary approach involving physicians, surgeons, dentists, and psychologists due to the absence of a definitive cure. For PRS types 1 and 2, fat and dermis grafts are deemed the most suitable treatment. Additionally, pan-facial volumization with autologous fat cartilage and bone graft-galea flap injection effectively replenishes volume and restores contour to the aging face in PRS types 3 and 4 [13,16]. Despite the availability of treatment options, the patient has chosen not to undergo any intervention. Regular and long-term follow-up is imperative to monitor disease progression and optimize treatment outcomes.

Conclusions

Parry-Romberg syndrome, also known as progressive hemifacial atrophy, is a rare neurocutaneous disorder characterized by the gradual degeneration of tissues on one side of the face. The complexity of its symptoms presents significant challenges in diagnosis and management, highlighting the need for a comprehensive, multidisciplinary approach involving dermatologists, neurologists, plastic surgeons, and other specialists. Despite ongoing research, the exact underlying causes of PRS remain unknown, emphasizing the critical need for extensive investigations to unravel its pathophysiology. More precise and effective treatment modalities can be developed by gaining a deeper understanding of the syndrome's mechanisms, ultimately improving the quality of life for individuals affected by this rare disorder. Continued research is essential for advancing innovative therapeutic interventions and enhancing healthcare outcomes for those grappling with PRS.

Disclosures

Author Contributions

Human subjects: Consent was obtained or waived by all participants in this study.

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following:

Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work.

Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.

Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Concept and design:  Harikrishnan Marappan, Raja AM

Acquisition, analysis, or interpretation of data:  Harikrishnan Marappan

Drafting of the manuscript:  Harikrishnan Marappan

Critical review of the manuscript for important intellectual content:  Harikrishnan Marappan, Raja AM
==== Refs
References

1 Linear scleroderma en coup de sabre. Relationship with progressive facial hemiatrophy (PFH) Adv Exp Med Biol Blaszczyk M Jablonska S 101 104 455 1999 https://pubmed.ncbi.nlm.nih.gov/10599329/ 10599329
2 Parry-Romberg syndrome: a global survey of 205 patients using the Internet Neurology Stone J 674 676 61 2003 12963760
3 Late-onset progressive facial hemiatrophy (Parry-Romberg syndrome) J Postgrad Med Mendonca J Viana SL Freitas F Lima G 135 136 51 2005 https://journals.lww.com/jopm/citation/2005/51020/late_onset_progressive_facial_hemiatrophy.24.aspx 16006711
4 The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993 J Rheumatol Peterson LS Nelson AM Su WP Mason T O'Fallon WM Gabriel SE 73 80 1 1997 https://europepmc.org/article/med/9002014
5 A significant proportion of children with morphea en coup de sabre and Parry-Romberg syndrome have neuroimaging findings Pediatr Dermatol Chiu YE Vora S Kwon EK Maheshwari M 738 748 29 2012 23106674
6 Clinical and serological characteristics of progressive facial hemiatrophy: a case series of 12 patients J Am Acad Dermatol Sommer A Gambichler T Bacharach-Buhles M von Rothenburg T Altmeyer P Kreuter A 227 233 54 2006 16443052
7 Parry-Romberg syndrome: facial atrophy and its relationship with other regions of the body Ann Plast Surg Duymaz A Karabekmez FE Keskin M Tosun Z 457 461 63 2009 19745718
8 Progressive facial hemiatrophy: Romberg's disease; a review of 772 cases Proc 3d Int Cong Plast Surg. Excerpta Medica ICS Rogers BO 681 689 66 1964 https://scholar.google.com/scholar?q=intitle:Progressive%20facial%20hemiatrophy%3A%20Romberg%27s%20disease%3B%20a%20review%20of%20772%20cases
9 Progressive hemifacial atrophy: a review Orphanet J Rare Dis Tolkachjov SN Patel NG Tollefson MM 39 10 2015 25881068
10 Scleroderma in children Best Pract Res Clin Rheumatol Zulian F 576 595 31 2017 29773274
11 Scleroderma 'en coup de sabre' and progressive facial hemiatrophy. Is it possible to differentiate them? J Eur Acad Dermatol Venereol Orozco-Covarrubias L Guzmán-Meza A Ridaura-Sanz C Carrasco Daza D Sosa-de-Martinez C Ruiz-Maldonado R 361 366 16 2002 12224693
12 Parry-Romberg syndrome in an adult: report of a case Ear Nose Throat J Fornwalt BE Altman JS 0 92 2013
13 Case 178: Parry-Romberg syndrome Radiology Sharma M Bharatha A Antonyshyn OM Aviv RI Symons SP 721 725 262 2012 22282187
14 Parry-Romberg syndrome: findings in advanced magnetic resonance imaging sequences - case report Radiol Bras de Paula RA Ribeiro BN Bahia PR Ribeiro RN de Carvalho LB 186 188 47 2014 25741077
15 Three-dimensional imaging of progressive facial hemiatrophy (Parry-Romberg syndrome) with unusual conjunctival findings Imaging Sci Dent Balan P Gogineni SB Shetty SR D'souza D 183 187 41 2011 22232729
16 Classification and treatment of facial tissue atrophy in Parry-Romberg disease Aesthetic Plast Surg Guerrerosantos J Guerrerosantos F Orozco J 424 434 31 2007 17700981
